Inhibikase Therapeutics Inc (IKT)

0.70 ↑0.04 (6.55%)
As of Market Close on January 30th, 2023.

IKT Chart

Your browser does not support this chart.

Your browser does not support this chart.

  • 52-Week Range: $0.46 - $1.48
  • Market Capitalization: $18.71M
  • Short Percentage: 0%
  • Target Price: $6.00
  • Shares Outstanding: 25.23M
  • Next Earnings: Nov 30
View More Stats

Catalysts

DateCategoryCatalyst
2022-03-31
Earnings

IKT released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.

Open: $1.51 Close: -1.95% Next Day: -4.60% Next Week: -7.25% View More
0 Comments Share
Help your fellow traders

News and Press Releases

Stock Details

  • Current Price: $0.70
  • 52-Week Low: $0.46
  • 52-Week High: $1.48
  • Most Recent Quarter: 2022-09-30
  • Shares Float: 18.28M
  • Shares Outstanding: 25.23M
  • Market Capitalization: $18.71M
  • Next Earnings Date: 0000-00-00

Short Interest

  • Shares Short
    (Today):     0
  • Short Ratio: 0.00
  • Shares Short
    (Last Month):     0
  • Short Interest: 0.00%

The short interest for Inhibikase Therapeutics Inc is at 0.00%, which is low amongst its peers.

Stock Ownership

Your browser does not support this chart.

Retail: 60.42%
Insiders: 21.32%
Instutitions: 18.26%

Analyst Target Price

6.00

Inhibikase Therapeutics Inc is currently $5.34 below Wallstreet Analysts' price target.

Yesterday's Volume

293,632

Interest in Inhibikase Therapeutics Inc has been trending down. The average daily volume in the past 14 days is 785,974.

Discussions

Please log in or register to share your thoughts.

beardedstocks6/19/22 12:33pm

$IKT Looks like a solid reversal - retesting support right now
definitely thinking about swinging this

0 Like Report